Rapid Micro Biosystems (NASDAQ:RPID) Announces Quarterly Earnings Results

Posted by Floyd Graber on Mar 1st, 2025

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.22), Zacks reports. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. The company had revenue of $8.22 million during the quarter, compared to analysts’ expectations of $8.20 million. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Price Performance

Shares of RPID opened at $3.05 on Friday. The company has a market capitalization of $131.25 million, a P/E ratio of -2.72 and a beta of 1.25. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $4.04. The business’s 50 day simple moving average is $1.95 and its 200-day simple moving average is $1.30.

Analyst Ratings Changes

Separately, KeyCorp began coverage on shares of Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 target price for the company.

Get Our Latest Stock Report on RPID

About Rapid Micro Biosystems

(Get Free Report)

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.